Home  »  Business   »  Take A Look At This Unity Biotechnology Inc. (NASD...

Take A Look At This Unity Biotechnology Inc. (NASDAQ: UBX) Analysis Before You Invest

Unity Biotechnology Inc. (NASDAQ:UBX) traded at $0.42 at close of the session on Wednesday, September 21, made a downward move of -6.07% on its previous day’s price.

Looking at the stock we see that its previous close was $0.45 and the beta (5Y monthly) reads 0.54 with the day’s price range being $0.432 – $0.4542. In terms of its 52-week price range, UBX has a high of $3.64 and a low of $0.42. The company’s stock has lost about -26.59% over that past 30 days.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Unity Biotechnology Inc. has a market cap of $64.91 million and is expected to release its quarterly earnings report on Mar 21, 2022 – Mar 25, 2022. Estimates by analysts give the company expected earnings per share (EPS) of -$0.28, with the EPS growth for the year raised at -$1.1 for 2022 and -$1.2 for next year. These figures represent -0.90% and -9.10% growth in EPS for the two years respectively.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the UBX stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.

Looking further, we note the current price level is -14.43% off its SMA20 and -37.13% from its 50-day simple moving average. The RSI (14) is pointing at 36.33 while the volatility over the past week is 5.57% and jumps to 7.48% over the past one month. The beta value is 0.71, while the average true range (ATR) is currently pointing at 0.10.

Coming back to Unity Biotechnology Inc. (NASDAQ:UBX), we note that the average 3-month trading volume was 3.82 million, while that of the preceding 10-day period stands at 1.34 million. Current shares outstanding are 140.23 million.

The insiders hold 1.20% of the company’s shares while institutions hold 17.00%. The data shows that short shares as of Jul 14, 2022, stood at 0.22 million at a short ratio of 0.5. This represents a 0.32% short interest in shares outstanding on Jul 14, 2022. Shares short fall in July from the previous month at 0.39 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -69.33% down in year-to-date price movement.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]